Abstract | Gastrointestinal motility results from coordinated contractions of the tunica muscularis, the muscular layers of the alimentary canal. Throughout most of the gastrointestinal tract, smooth muscles are organized into two layers of circularly or longitudinally oriented muscle bundles. Smooth muscle cells form electrical and mechanical junctions between cells that facilitate coordination of contractions. Excitation-contraction coupling occurs by Ca 2+ entry via ion channels in the plasma membrane, leading to a rise in intracellular Ca . Ca 2+ binding to calmodulin activates myosin light chain kinase; subsequent phosphorylation of myosin initiates cross-bridge cycling. Myosin phosphatase dephosphorylates myosin to relax muscles, and a process known as Ca 2+ sensitization regulates the activity of the phosphatase. Gastrointestinal smooth muscles are 'autonomous' and generate spontaneous electrical activity (slow waves) that does not depend upon input from nerves. Intrinsic pacemaker activity comes from interstitial cells of Cajal, which are electrically coupled to smooth muscle cells. Patterns of contractile activity in gastrointestinal muscles are determined by inputs from enteric motor neurons that innervate smooth muscle cells and interstitial cells. Here we provide an overview of the cells and mechanisms that generate smooth muscle contractile behaviour and gastrointestinal motility.
Introduction
The gastrointestinal tract is a series of tubular organs that process ingested food, assimilate water and nutrients, and eliminate waste. The outer layers of the gut wall are muscular tissues (tunica muscularis) that provide the forces necessary to stir the contents of the gut and move food, water and waste through the tubular chambers. In the human gastrointestinal tract, the muscles in the proximal two-thirds of the oesophagus and in the external anal sphincter are skeletal; the rest of the tunica muscularis contains smooth muscle cells (SMCs). Gastrointestinal smooth muscles are autonomous-generating spontaneous electrical rhythmicity and contractions driven by intrinsic pacemakers, Ca 2+ handling and Ca 2+ sensitization mechanisms. SMCs contracting independently at their own whim would not produce useful movements; however, electrical and mechanical junctions formed with neighbouring cells create a syncytium that facilitates coordination of contractions of thousands of cells. This level of cooperation is still not sufficient to produce gastrointestinal motility patterns and orderly progression of luminal contents. Multiple levels of regulatory cells and mechanisms, including interstitial cells, motor neurons, hormones, paracrine substances and inflammatory mediators, are superimposed upon myogenic activity to generate normal and abnormal contractile behaviours (Figure 1 ). It should also be noted that smooth muscle tissues of the gastrointestinal tract are not homogenous. Differences exist in the behaviours of circular and longitudinal muscles, and in the muscles of each of the four major organs. There are also important differences in electrical and mechanical activities in different regions of organs and in the sphincters separating the organs. Here we review the cells and general mechanisms that generate smooth muscle electrical and contractile behaviours and gastrointestinal motility.
Design of the smooth muscle motor
Specialized binding of actin and myosin results in crossbridge formation and cycling, and force generation in smooth muscles. Myosin is a hexametric protein with parallel functions as a force-generating motor protein and enzymatic activity for the hydrolysis of ATP.
1,2
Smooth muscle myosin is composed of two 200 kDa heavy chains that are each associated with two light chains: a 20 kDa regulatory subunit (MLC20), and a 17 kDa (MLC17) nonphosphorylatable subunit. The N-terminal ends of the heavy chains form globular heads with enzymatic activity and sites for actin binding. MLC20 and MLC17 bind to the neck region of myosin heads. Four isoforms of myosin heavy chains are found in smooth muscles, resulting from transcription of MYH11 and alternative splicing.
3-5 Two isoforms, 204 kDa (SM1) and 200 kDa (SM2) result from a splice site at the COOH terminus, and two isoforms (SMB and SMA) result from a splice site in the S1 head region. Various combinations of these isoforms (for example, SM1A or SM1B) have tissue and cell specific distributions in different smooth muscles. Typically, SM1 and SM2 are about equally distributed in smooth muscle cells, 6 but substantial diversity ■ Gastrointestinal motility occurs by the coordinated contractions of the tunica muscularis, which forms the outer wall of the alimentary canal from the distal oesophagus to the external anal sphincter ■ Excitation-contraction coupling results from Ca 2+ entry into smooth muscle cells, Ca 2+ release from the sarcoplasmic reticulum, activation of myosin light chain kinase and phosphorylation of the regulatory light chains of myosin ■ Contractile force is tuned by Ca 2+ sensitization mechanisms that balance rates of myosin phosphorylation and dephosphorylation ■ Interstitial cells of Cajal (ICC) provide spontaneous pacemaker activity in gastrointestinal muscles; ICC and PDGFRα + cells also contribute to mediation of inputs from enteric motor neurons ■ Gastrointestinal motility patterns are highly integrated behaviours requiring coordination between smooth muscle cells and utilizing regulatory inputs from interstitial cells, neurons, and endocrine and immune cells ■ Therapeutic regulation and tissue engineering of gastrointestinal motility is proving difficult exists in the expression of SMA and SMB isoforms. In the fundus, for example, SMA is the dominant isoform, whereas SMB increases with distance from the fundus to the antrum and represents the dominant isoform in antral muscles. 6 There is also diversity in myosin heavy chain isoform expression between cells within a given tissue, but the functional importance of this cellular hetero geneity is not yet understood. 7 Contractions are initiated by phosphorylation of MLC20 by Ca 2+ /calmodulin-dependent myosin light chain kinase or Ca 2+ -independent kinases, including Rho-kinase, integrin-linked kinase and zipperinteracting protein kinase (ZIPK; Figure 2) . [8] [9] [10] [11] An increasing level of cytoplasmic Ca 2+ ([Ca 2+ ] i ) is the main physiological event that activates myosin light chain kinase. Phosphorylation of MLC20 facilitates myosin binding to actin, initiating cross-bridge cycling and force development. MLC20 phosphorylation and contraction are balanced by myosin light chain phosphatase (MLCP). MLCP is composed of three subunits. 12 One of these subunits (myosin phosphatase target subunit; MYPT) anchors MLCP to phosphorylated MLC20 and targets a 37 kDa catalytic subunit (type 1 serine/threonine phosphatase, PP1c), to myosin. 13 Phosphorylation of MYPT (see below) can dramatically affect the balance between phosphorylated and dephosphorylated MLC20; therefore, regulation of MLCP can be a powerful means for modulating the force of contractions.
Excitation-contraction coupling
Studies of several species have provided a general concept of excitation-contraction coupling in mammalian gastro intestinal smooth muscles, but these studies have also demonstrated considerable diversity in the expression of ionic conductances in different species and in different regions of the gastrointestinal tract. The ionic channels in human gastrointestinal smooth muscles responsible for excitation-contraction coupling and the specific responses of human muscles to neurotransmitters and other regulatory agents have not been studied in enough depth to clearly describe excitationcontraction coupling mechanisms in human gastrointestinal smooth muscles. Nonetheless, pertinent data are described below, including seminal findings from other smooth muscle types and gastro intestinal muscles of laboratory animals.
Voltage-dependent calcium channels
Like all excitable cells, the resting potentials of SMCs in gastrointestinal muscles are negative relative to the interstitium. Na + and Ca 2+ are not in equilibrium across the cell membrane, such that a rise in membrane permeability to these ions causes rapid influx. Inward currents (defined as an influx of positive charges) result in membrane depolarization. Excitation-contraction coupling is triggered by a rise in [Ca 2+ ] i . 8, 9 An important feature of the excitation-contraction coupling mechanism is linked to the depolarization of SMCs. and TRPC6 encode the nonselective cation channels activated by muscarinic stimulation (as shown by gene deactivation). 20 TRP channels are voltage-independent and activated either by intracellular Ca 2+ or by G-proteincoupled mechanisms. 21 Other nonselective cation channels-activated by other agonists, such as neurokinins and hormones-have slightly different properties. 22 For example, a well-known property of nonselective cation channels activated by muscarinic stimulation is potentiation by intracellular Ca 2+ . 23 This property is not apparent in channels activated by neurokinins. The role of the sarcoplasmic reticulum SMCs store Ca 2+ in intracellular organelles, the most prominent of which, in relation to excitation-contraction coupling, is the sarcoplasmic reticulum. 28 
Ca
2+ sensitization is controlled through the activity of MLCP (Figure 2 ). Contraction is initiated by phosphorylation of myosin (MLC20), so dephosphorylation of myosin reduces contraction. Phosphorylation of MYPT (the regulatory subunit of MLCP) reduces the activity of the phosphatase and sustains cross-bridge cycling and contraction. 47, 48 Rho kinase was the first enzyme shown to phosphorylate MYPT, but ZIPK is also known to phosphorylate MYPT and enhance Ca 2+ sensitization. 49, 50 CPI-17 is another signalling molecule that regulates MLCP. When phosphorylated by protein kinase C, Rho kinase or other kinases, CPI-17 binds to the catalytic subunit of MLCP and inhibits dephosphorylation of MLC20. 8, 47 As discussed above, acetylcholine is coupled to responses via M 2 and M 3 receptors. M 3 receptors are coupled through G q/11 to production of diacylglycerol and IP 3 cGMP-dependent Ca 2+ desensitization is mediated, in part, via protein kinase G phosphorylation of RhoA at serine 188 (S188), which prevents its binding to Rho kinase and decreases Ca 2+ sensitization. 53 This mechanism explains inhibition of Ca 2+ sensitization by cyclic nucleotide-dependent mechanisms, but additional pathways are needed to fully explain a rightward shift in the Ca 2+ -force relationship, the hallmark of Ca 2+ desensitization. Telokin, a small acidic protein with partial sequence homology to myosin light chain kinase, is phosphorylated at serine 13 (S13) in response to 8-bromo-cGMP or forskolin and tends to stabilize the unphosphorylated state of MLC20. 54 Thus, cGMP-dependent and cAMPdependent Ca 2+ desensitization might be mediated through telokin. Studies on telokin null mice demonstrate that telokin enhances the activity of MLCP, thus reducing Ca 2+ sensitivity. 55 Ca 2+ sensitization mechanisms are important regulatory pathways in gastrointestinal SMCs, and might provide novel therapeutic strategies for controlling gastrointestinal motility. Whether regulation of Ca 2+ sensitization mechanisms contribute to responses to neurotransmitters released from neurons is unknown. These mechanisms have been studied by adding neurotransmitters to muscles immersed in organ baths in which all cells in the muscles are exposed to agonists. As discussed below, neurotransmitter binding might be restricted to receptors in neuroeffector junctions. If this is the case, then neurotransmitter responses might not be mediated by the same receptors and pathways affected by exogenous, bath-applied agonists.
Regulation of smooth muscle by motor neurons
Motility patterns in the gastrointestinal tract depend upon control of muscles by enteric neurons. The motor responses of gastrointestinal muscles have been studied for many years, and considerable progress in identifying neurotransmitters and clarifying postjunctional mechanisms has been made (Table 1) . Gastrointestinal muscles are innervated by inhibitory and excitatory nerves. 56, 57 Control by enteric neurons enables complex motor patterns, such as the peristaltic reflex, segmentation, regulation of tonic contractions (such as receptive relaxation) and control of sphincters. The peristaltic reflex, a stereotypical response of gastrointestinal muscles, consists of contraction at, or above, the site of stimulation and relaxation below the site of stimulation. [58] [59] [60] [61] A poststimulus excitatory response follows the inhibitory response ('rebound' excitation), 62, 63 and constitutes a third phase of the peristaltic reflex.
Excitatory and inhibitory neurotransmitters
Gastrointestinal smooth muscle responses depend upon excitatory and inhibitory neurotransmitters. These molecules are linked to complex cell signalling pathways through a variety of receptors in postjunctional cells (Table 1) . Acetylcholine is the most prominent excitatory neurotransmitter, and postjunctional responses are mediated by muscarinic receptors (M 2 and M 3 ). 20, 32, 33, 64, 65 Neurokinins (substance P and neurokinin A) bind to NK1 and NK2 receptors and activate pathways similar to acetylcholine. 22, [66] [67] [68] [69] Nitric oxide (NO) is now considered the predominant inhibitory neurotransmitter, 70, 71 and it is coupled, via nontraditional postjunctional receptors (that is, cyto plasmic proteins), to activation of guanylyl cyclase leading to production of cGMP, activation of protein kinase G, activation of K + channels and decreased Ca 2+ sensitivity. 53, 55, 72, 73 The purine neurotransmitter is inhibitory in gastro intestinal smooth muscles and has long been thought to be ATP. In fact, the purine neuro transmitter might be β-nicotinic adenine dinucleotide (β-NAD), because this nucleotide better fulfils the criteria for a neuro transmitter. 74, 75 Purines bind to P2Y1 receptors in postjunctional cells, elicit production of IP 3 and diacylglycerol, and activate SK channels and hyperpolarization. [76] [77] [78] In some regions of the gut, vasoactive intestinal polypeptide and/or pituitary adenylate cyclase-activating polypeptide (PACAP) also contribute to inhibitory neurotransmission, but these substances are released generally at high stimulus frequencies of nerve stimulation (≥10 Hz). 79, 80 Vasoactive intestinal poly peptide and PACAP act through VPAC1/2 receptors coupled to G s , leading to activation of adenylyl cyclase, generation of cAMP and activation of cAMP-dependent protein kinase A. 81, 82 This pathway generally reduces excitability and contraction by activating K + channels and by reducing the Ca 2+ sensitivity of the contractile apparatus. 8, 81 Excitatory and inhibitory neurotransmitters are released from distinct populations of excitatory and inhibitory motor neurons. Postjunctional responses are determined by a series of factors, including: first, which cells are in close proximity to the sites of neurotransmitter release (once released, transmitters might be rapidly metabolized or 'deactivated' by diffusion as the concentration of the transmitter is diluted into the postjunctional interstitium); second, which cells express appropriate receptors for specific neurotransmitters (all cells in the postjunctional, neuro-effector field might express receptors for a given transmitter, but responses might be elicited by specific receptors expressed by only one type of cell); and third, which ionic conductances or effector mechanisms are linked to second messenger pathways in postjunctional cells.
Neuropeptides in motility responses
Excitatory and inhibitory neurons also express neuropeptides that regulate the motor control of gastrointestinal muscles. 83 This topic is less well-described in the literature because peptidergic responses are only elicited in most gastrointestinal muscles at higher frequencies of enteric nerve firing (usually >5 Hz). At lower frequency stimulation, responses can normally be blocked entirely by a combination of M 2 and M 3 muscarinic receptor blockers, P2Y1 receptor blockers, and NO synthesis inhibitors. 75 The physiological firing frequencies of enteric neurons during enteric reflexes are poorly documented, but the fact that the same antagonists and inhibitors can block peristaltic reflex responses, receptive or adaptive relaxation, and lower oesophageal opening, suggests that many motility responses depend on the small molecule neurotransmitters NO, acetylcholine and β-NAD/ATP. The peptides seem to be reserved for more extreme conditions or possibly when other motor pathways are compromised.
The role of interstitial cells

ICC
Many gastrointestinal smooth muscle tissues and organs display 'autonomous' activity. Spontaneous pacemaker activity in the stomach, small intestine and colon (electrical slow waves) organizes contractile patterns into phasic contractions that are the basis for peristaltic or segmental motility patterns. 84 Pacemaker activity is intrinsic to gastrointestinal muscles and does not depend on neural or hormonal inputs, although the degree of coupling between pacemaker activity and contractions is highly dependent on neural and other regulatory inputs. Basal slow wave activity generates low amplitude contractions, and inhibitory or excitatory neural inputs modulate the amplitude of contractions during each cycle.
In the 1960s and 1970s Ladd Prosser's group at the University of Illinois suggested that longitudinal muscle was the source of pacemaker activity; 85 however, only excised muscles retaining a bit of the myenteric plexus tissue were spontaneously active. Morphologists suggested that ICC might be pacemakers, because these cells form networks and make gap junctions with SMCs. 86, 87 When pacemaker regions within gastrointestinal muscles were mapped during the 1980s, areas from which pacemaker activity emanated were found to be populated by ICC. [88] [89] [90] ICC form networks within the tunica muscularis along the corpus and antrum of the stomach and throughout the small intestine and the colon. Unlike in the heart, unique pacemaker sites do not exist in gastrointestinal organs.
Isolated gastrointestinal SMCs do not typically generate electrical rhythmicity. Depending on the type of cell and its membrane potential, SMCs can generate fast Ca 2+ action potentials, but not the slow waves typical of gastro intestinal muscles. Isolated ICC display spontaneous electrical rhythmicity similar to the electrical activity of intact muscles. 91, 92 However, proof for the role of ICC as pacemakers occurred when animals with loss-of-function in c-Kit signalling were found to lack pacemaker ICC in the small intestine and failed to generate pacemaker activity. [93] [94] [95] Labelling of ICC with antibodies against c-Kit, and manipulating ICC populations by blocking c-Kit or using mutant animals with abnormal c-Kit function, opened the door for large scale assessment of the role of ICC in the function of smooth muscle organs. For example, immunohistochemical techniques enabled efficient characterization of the distribution of ICC in every region of the gastrointestinal tract, and implementation of c-Kit labelling in clinical pathology laboratories demonstrated loss of ICC in gastrointestinal muscles of patients with a variety of motor pathologies. 96, 97 This approach also helped to develop the hypothesis that gastrointestinal stromal tumours (GISTs) originate from ICC. 98 A striking finding from c-Kit immunohistochemistry is the well-defined patterning of ICC distribution in smooth muscles. In pacemaker regions, ICC are typically multipolar cells making frequent gap junctions with each other and thus forming an electrical network.
99-102 ICC within muscle bundles (intramuscular ICC), however, are typically bipolar cells with few processes extending from the central axis, and they track along the axons of enteric motor neurons (excitatory and inhibitory).
99,100,102
The pacemaker mechanism of ICC ICC constitute a small population of cells (<10%) within the tunica muscularis, and it is difficult to study the pacemaker mechanism in these cells in situ. The identification of ICC in the myenteric region (ICC-MY), verified by filling of cells with fluorescent dyes, revealed large amplitude electrical slow waves in these cells. 103, 104 Simultaneous recording from ICC-MY and nearby SMCs demonstrated four important phenomena: 103, 105 first, slow waves in ICC-MY and SMCs are coordinated; second, slow waves in ICC-MY slightly preceded the slow waves in SMCs, suggesting they originated in ICC-MY; third, slow waves were of greater amplitude in ICC-MY and conducted with decrement (that is, passively) to SMCs, demonstrating that slow waves cannot be regenerated by SMCs; and fourth, ICC-MY are electrically coupled to SMCs. We believe these observations explain why continuous networks of ICC are needed in regions of the gastrointestinal tract with phasic electrical and mechanical activity: ICC provide a pathway for the active propagation of slow waves and therefore provide a means of coordinating organ-level propagation of contractions and creating the basis for motility patterns.
Isolation of ICC permitted studies of the pacemaker mechanism. ICC tend not to retain either their characteristic morphologies or c-Kit immunoreactivity after enzymatic dispersions of muscles. Therefore, cell culture techniques were developed, and immuno-identification with c-Kit antibodies is possible after one or two days in culture. 106, 107 ICC grow and develop networks and electrical rhythmicity in cell culture, but when cells are dispersed and removed from the extracellular matrix, they experience substantial phenotypic changes within a few days. 104 Studies of cultured ICC have reported a wide variety of ionic conductances but have failed to reveal the key conductance required for slow wave activity, owing to the apparent loss of the ion channels responsible in cultured cells. 108 A transgenic animal was developed with a bright green fluorescent protein (GFP), copGFP, expressed in ICC 108, 109 to make it possible to identify freshly dispersed ICC unequivocally. Single ICC from these animals displayed spontaneous transient depolarization and spontaneous slow waves. Slow waves with properties of a Ca 2+ -activated Cl -current were elicited by depolarization in ICC; these currents and slow waves were blocked by niflumic acid (a molecule that inhibits Cl -channels). Slow waves were also blocked by niflumic acid in mouse and human gastrointestinal muscles, and transgenic mice carrying deactivated Tmem16a, which encodes Ca 2+ -activated Cl -channels, displayed normal appearing ICC networks but no slow waves. 110 Thus, from studies of freshly isolated ICC and genetically modified animal models, it seems that pacemaker activity in the gastrointestinal tract is due to periodic release of Ca 2+ from intracellular stores and activation of a Ca 
The role of ICC in motor neurotransmission
Intramuscular ICC are closely associated with varicose terminals of enteric motor neurons, as observed initially with electron microscopy. 111, 112 The hypothesis that ICC might have a role in mediating inputs from enteric motor neurons, first suggested by morphologists, [111] [112] [113] was strengthened by observing close appositions between ICC and neurons with double immuno labelling using antibodies for c-Kit and antibodies specific for neurons. 99 Intramuscular ICC form gap junctions with nearby SMCs, making it possible for responses to neuro transmitters to be conducted to the smooth muscle syncytium. 87, 111, 112 Molecular studies have demonstrated that ICC have the receptors required for transduction of neurotransmitter signals, 114, 115 and that prejunctional and postjunctional synaptic proteins are arranged at the interface between ICC and enteric varicosities. 116 Physiological studies show that responses to cholinergic and nitrergic nerves are reduced in animals with defective c-Kit signalling. 99, 117, 118 Thus, some motor pathologies associated with loss of ICC might be caused by reduced communication between enteric motor neurons and SMCs.
The role of ICC in motor neurotransmission has been challenged by studies of c-kit mutants in which contractile responses were elicited by repetitive field stimulation. 119, 120 These studies suggest that transmitter overflow during repetitive stimulation is sufficient to elicit postjunctional responses whether ICC are present or not. These experiments might indicate that parallel innervation of ICC and SMCs is normal and that inputs to SMCs can compensate when ICC are absent. In the normal gastrointestinal tract, however, ICC might effectively shield other cells from neurotransmitters. In the very small (<20 nm) regions between ICC and enteric nerve varicosities (neuro-ICC junctions), high concentrations of neurotransmitters might be achieved during neurotransmission, which could enhance the rate of metabolism of transmitters. 112 Thus, when ICC are absent, transmitters might be available to bind to receptors of other postjunctional cells. 121 An extensive review describing the controversy about the role of ICC in motor neurotransmission is available. 121 Future studies to characterize which cell-specific effectors are activated in response to neurotransmission or which key receptor and effector genes are deactivated in specific cell-types will be needed to clarify the role of ICC in neuro transmission. For example, muscarinic agonists stimulate different ion channels in SMCs and ICC. Postjunctional responses to cholinergic nerve stimulation in the small intestine have been shown to be mediated by ion channels expressed by ICC (that is, Ca 2+ -activated Cl -channels) but not by SMCs. 122 These data suggest that neurotransmitters released from nerve terminals might bind to receptors on ICC but not reach muscarinic receptors expressed by SMCs.
In our view, low resistance, electrical coupling between ICC and SMCs is essential for the functions of ICC in gastrointestinal muscles. Ultrastructural studies have provided evidence that gap junctions exist between ICC and SMCs; 86, 87, 111, 123 however, the junctions between ICC-MY and SMCs seem to be small and relatively rare. 124 Electrical coupling between these cells is clearly evident, however, from electrophysiological studies. 105 Several studies have investigated the expression of connexin proteins (gap junction proteins). SMCs and ICC express connexin 43 105, 125, 126 and connexin 40 immunoreactivity has also been observed in the dog. 127 Connexin 45 might be specific to gap junctions between ICC. 126 
PDGFRα
+ cells Purines, one of the inhibitory neurotransmitters released from enteric motor neurons, are weakly active on gastrointestinal SMCs. 128, 129 A new type of interstitial cell in gastrointestinal muscles has been shown to respond to purines. 76 Electron microscopy previously described a non-ICC type of interstitial cell in gastrointestinal muscles. These cells, referred to as fibroblast-like cells, are found near terminals of motor neurons and form gap junctions with SMCs. [130] [131] [132] Fibroblast-like cells express small conductance Ca 2+ -activated K + channels, SK3 (encoded by KCNN3), [133] [134] [135] [136] which might be activated in purinergic inhibitory responses. These fibroblast-like cells are labelled with antibodies to PDGFRα, and PDGFRα + cells express SK3 channels and P2Y1 receptors. 76, 135, 136 These proteins are key in purinergic inhibitory regulation of gastrointestinal motility. [76] [77] [78] A transgenic animal with enhanced GFP targeted to PDGFRα + cells was used to isolate these cells and test their responsiveness to purine neurotransmitters. 76 Purine neurotransmitters elicited large amplitude K + currents in PDGFRα + cells that were blocked by P2Y1 receptor antagonists and SK3 channel antagonists. Under the same experimental conditions (that is, ionic gradients and holding potentials equivalent to resting potentials in gastrointestinal muscles), purines failed to elicit outward currents in SMCs. 76 These data suggest that the large amplitude hyperpolarization responses elicited in gastrointestinal muscles by purine neurotransmission (inhibitory junction potentials) are more likely to be meditated by PDGFRα + cells than by SMCs.
Integration of behaviour in the SIP syncytium
Gastrointestinal motility, resulting from coordinated contractions of thousands of SMCs, is a highly integrated phenomenon (Figure 1 ). Ionic channels in the plasma membrane and basal levels of contractile protein phosphorylation set the excitability and contractility of SMCs. SMCs are electrically coupled, so conductance changes in one cell or group of cells can influence the excitability of the broader syncytium of cells. Superimposed on myogenic mechanisms are the behaviours of inter stitial cells (ICC and PDGFRα + cells) that are electrically coupled to the smooth muscle syncytium. Thus, the myogenic apparatus is an electrical syncytium consisting of SMCs/ ICC/PDGFRα + cells or the 'SIP syncytium' . Activation of ion channels in any of these cells can affect voltagedependent channels in SMCs. For example, activation of Ca 2+ -activated Cl -channels in ICC generates inward currents, producing slow waves. Slow waves conduct to SMCs producing cycles of depolarization that can activate Ca 2+ channels and couple slow waves to smooth muscle contractions. Superimposed on the summed activity of smooth muscle and interstitial cells are inputs from enteric motor neurons. As we have seen, neurotransmitters can activate conductances in SMCs and interstitial cells (for example, Ca 2+ -activated Cl -channels or K + conductances in ICC or SK3 channels in PDGFRα + cells) that enhance (net inward currents) or reduce (net outward currents) the excitability of the SIP syncytium. When neurotransmitters bind to receptors of SMCs, mechanisms of Ca 2+ sensitization or desensitization regulate contractile responses. In addition to these mechanisms are layers of regulation including circulating hormones, local paracrine substances and inflammatory mediators. Inputs from some endogenous bioregulatory molecules can modulate smooth muscle responses such that otherwise normal behaviours of SMCs, interstitial cells and motor neurons result in inappropriate motility (paralysis or hypercontractile states). Such dysmotilities can adversely affect movements of food, absorption of nutrients and water, and transit of wastes.
New therapeutic strategies
Tissue engineering of gastrointestinal muscles Motility disorders can result from developmental failures and disease processes that compromise function or from surgical interventions that remove portions of gastrointestinal muscle. Regenerative medicine raises hope that some of these problems might be corrected through engineering functional gastrointestinal muscles, and progress has been made in this field during the past decade. However, the complex organization and plasticity of cells within the SIP syncytium, vascularization, and immunological constraints are major obstacles to accomplishing this feat.
Tissue engineering of gastrointestinal muscles has benefitted from attempts to develop vascular grafts. Nearly 250,000 patients per year undergo coronary bypass surgery, and up to one-quarter of these patients do not have suitable autologous vessels for the bypass. 137 Thus, extensive effort has gone into engineering blood vessel segments that might be suitable for bypass procedures, and there has been considerable investigation of soluble signalling factors, mechanical stimulation, extracellular matrix, scaffolding materials, and how other cells influence smooth muscle phenotypes. 138 The use of differentiated SMCs as a starting point in tissue engineering is complicated by the tendency of these cells to dedifferentiate from a contractile phenotype to a synthetic or proliferative phenotype. Initially, the phenotypic plasticity is useful to expand the SMCs from a biopsy sample, but inducing proliferating SMCs to return to the contractile phenotype is problematic. Although several groups have attempted to engineer gastrointestinal muscles by a variety of techniques, 139 it has been considerably more difficult to accomplish than for vascular tissue owing to the multiple cell types that contribute to postjunctional integration of neural inputs and regulation of motility.
One promising area might be to grow sphincteric muscles from dispersed smooth muscle tissues because the motility in sphincters is far easier to simulate than complex motility patterns in most regions of the gastrointestinal tract. Some successes have been achieved with engineering of sphincteric tissues, and rings of muscle have been grown and grafted into animals to stimulate vascularization. 140, 141 The muscle rings were characterized for expression of α-actin and caldesmon. However, we believe that demonstration of only a few proteins represents a low standard for verification of a contractile smooth muscle phenotype, and we have previously suggested that more vigorous phenotyping is necessary in studies of this type (see below). 27 Functional studies showed that engineered muscle rings developed low levels of spontaneous tone and responded to excitatory and inhibitory neurotransmitters. 140, 141 In other studies, human muscle cells have been co-cultured with neurons from imortomice donors, and cells immunopositive for vasoactive intestinal polypeptide and choline acetyltransferase developed within the engineered muscle rings. 140, 141 However, in our opinion, the histological images of the engineered muscle rings provided in these papers suggest that the predominant cells grown in the muscular rings were skeletal muscles, not SMCs (for example, cells are multinucleated and much larger than expected for SMCs 140 ). Much is now known about the 'excitasome' of SMCs (that is, the genes transcribed to generate proteins essential for smooth muscle function and phenotype); several essential pathways have been discussed in this Review. Modern genomic or sequencing techniques could easily assay gene expression in engineered smooth muscle tissues or cultured cells to verify the degree to which so-called SMCs and tissues recapitulate the phenotype of native SMCs. As described in this Review, gastrointestinal smooth muscle behaviours result from coordinated activity of several types of cells (for example, motor neurons, cells of the SIP syncytium, etc.). We feel that progress toward successful tissue engineering of gastrointestinal smooth muscles will be slow until more rigorous standards of evaluating tissue structure, cellular composition and SMC phenotype are employed.
MicroRNAs
Another therapeutic approach might be the molecular regulation of transcription factors that regulate the smooth muscle phenotype. Genes that determine the smooth muscle phenotype are regulated by serum response elements (CArG boxes) in promoter/enhancer regions, to which the transcription factor serum response factor (SRF) binds. 142 The actions of SRF are regulated by myocardin (MYOCD) and ELK1. 143 Studies have shown that the differentiation and growth of SMCs are regulated by microRNAs (miRNAs; for example, miR-1, miR-21, miR-133a, miR-143, and miR-145 [144] [145] [146] ) and some miRNAs are regulated by SRF via at least one CArG box in promoter regions of miRNAs. Sequencing techniques have been used to identify genome-wide miRNAs in human and mouse intestinal smooth muscles. 146 There are hundreds of unique miRNAs in human and mouse small intestinal muscles that are highly conserved between the two species. Two miRNA clusters, miR-143/ miR-145 and miR-199a/miR-214, induced by SRF, regulate SMC differentiation and proliferation, respectively. 146 A distinctive group of miRNAs regulating SMC phenotype are induced or repressed in differentiated or proliferating SMCs; for example, miR-143, miR-145, miR-1, and miR-133a are highly expressed in differentiated SMCs but repressed in proliferating SMCs, while miR-214, miR-199a, and miR-21 are highly expressed in proliferating SMCs but repressed in differentiated SMCs. 146 Gain-of-function or loss-of-function studies with these phenotypic miRNAs demonstrated that each miRNA could switch SMC phenotype between the proliferating and differentiated state. [145] [146] [147] [148] [149] [150] [151] The pheno typic miRNAs remodel SMCs in two antagonistic pathways that promote one way and silence the other (Figure 3) . SMC-specific deletion of Dicer, the endonuclease responsible for production of mature micro RNAs, 152 caused failure in development of normal smooth muscle layers in the gastrointestinal tract, and contractile genes and transcription factors were down-regulated. 153 Thus, miRNAs are essential for the development and establishment of the SMC phenotype, and manipulating these molecules might enable control of smooth muscle growth and development.
Conclusions
Smooth muscle contractions and motility result from the integrated behaviour of at least three types of cells: SMCs, ICC and PDGFRα + cells, forming the SIP syncytium. The behaviour of the SIP syncytium, and ultimately the excitability and contractility of SMCs, are modulated by regulatory elements such as enteric motor neurons, hormones and paracrine substances. Although much has been learned about the functions and molecular mechanisms of SMCs, ICC and PDGFRα + cells, highly specific therapeutics for gastrointestinal motility disorders remain elusive. Several reasons exist for this shortcoming. Although smooth muscles of the gastrointestinal tract have different properties than smooth muscles in other organs, many mechanisms are very similar. Most knowledge about gastrointestinal motility comes from studies of specific regions of the gastrointestinal tract or from animal models. There is diversity in circular and longitudinal muscles and from site to site in the mechanisms that regulate smooth muscle excitability, excitation-contraction coupling, regulation of contractile force, and expression of receptors for regulatory agonists. Diversity also exists between species. These differences make extrapolation from what is learned from studies of one muscle layer, one region or one species to other regions, tissues and species tenuous. Unfortunately, considerably less is known about regulation of smooth muscle function in human gastrointestinal muscles. Considering their morphology, ICC and PDGFRα + cells might have similar functions in the human gastrointestinal tract, but the presumed function of these cells in humans is only hypothetical at present.
This diversity between regions of the gastrointestinal tract and between species complicates the development of therapeutics. Until hypotheses can be tested on human muscles, ideas for pursuing a particular therapy are risky. Another complicating factor is that motility disorders might not be manifested throughout the gastrointestinal tract. Constipation resulting from hypomotility in the colon may not be accompanied by weakened contractions in other areas of the gastrointestinal tract. Thus, if a treatment is devised to increase motility in one region, there is risk that it could negatively effect motility in another region. Finally, it must also be recognized that the normal phenotype of gastrointestinal smooth muscles is quite similar to smooth muscles of other organs. Thus, attempts to manipulate molecular targets in gastrointestinal smooth muscles could result in potentially life-threatening complications in other organs. At present, few specific therapeutic targets have been identified in gastrointestinal smooth muscles, and few efficacious compounds are currently available for treatment of motility disorders. Hope for the future will come from improved understanding of cellular and molecular mechanisms in human muscles and the identification of more specific pathways in the cells involved in specific behaviours. Techniques for the specific delivery of drugs or specific manipulation of cell phenotypes might also be beneficial. Many patient groups push for cures and treatments based on current knowledge, but far more basic science is needed to provide safe and efficacious therapeutics for gastrointestinal motility disorders. 
Review criteria
To prepare this Review we used our extensive collections of articles related to smooth muscle biology and neurogastroenterology and searched additional topics through the PubMed database using the following search terms: "smooth muscle", "gastrointestinal motility", "Ca2+ sensitization", "excitation-contraction coupling" and "enteric nervous system". The points made in this Review were included after consideration of the entire texts of the articles cited. Findings from studies of smooth muscles outside the gastrointestinal tract were also cited in this Review. These citations were chosen because they were either seminal discoveries of important regulatory pathways common to smooth muscles or because studies of gastrointestinal smooth muscles of equivalent quality and rigour were not apparent. Identification of a novel smooth muscle myosin heavy chain cDNA: isoform diversity in the S1
